escitalopram + aripiprazole + omega-3 pufas

This is a combination therapy consisting of three agents: - **Escitalopram** is a selective serotonin reuptake inhibitor (SSRI) used primarily for major depressive disorder and generalized anxiety disorder. It works by inhibiting the serotonin transporter, increasing serotonin levels in the synaptic cleft[6]. - **Aripiprazole** is an atypical antipsychotic that acts as a partial agonist at dopamine D2 and serotonin 5-HT1A receptors and as an antagonist at 5-HT2A receptors. It is used for schizophrenia, bipolar disorder, and as adjunctive treatment in major depressive disorder[7]. - **Omega-3 polyunsaturated fatty acids (PUFAs)** are dietary supplements with anti-inflammatory properties; they have been studied for mood-stabilizing effects in psychiatric disorders such as depression and bipolar disorder. Their mechanism may involve modulation of cell membrane fluidity, neurotransmitter function, and reduction of oxidative stress[4][7]. This combination has been explored in research settings for mood disorders—particularly treatment-resistant depression or bipolar disorder—where augmentation strategies are needed. There is evidence supporting the use of each component individually or in pairs; however, clinical data on all three together are limited to preclinical studies or small trials[3][7]. The rationale behind this combination includes targeting multiple neurochemical pathways involved in mood regulation.

Other names

escitalopram + aripiprazole + omega-3 polyunsaturated fatty acidsescitalopram + aripiprazole + fish oil